Monjaro weight loss injection: a plain guide to how it works

Step 1: understanding what the injection actually does in your body

Tirzepatide (the active ingredient in Mounjaro) mimics two naturally occurring gut hormones: GIP and GLP-1. Both are released after eating, and both signal to the brain that you have had enough. By activating those two receptors simultaneously, the medicine reduces appetite more consistently than earlier single-pathway injections. It also slows gastric emptying, so food moves through your stomach more gradually, extending the feeling of fullness after a meal.

This dual mechanism is the reason tirzepatide is described on the NHS tirzepatide medicines page as distinct from GLP-1-only treatments. The biology matters practically: many people find their hunger fades noticeably within the first few weeks, though individual responses vary and a prescriber reviews progress regularly to decide whether titration is appropriate.

A question our prescribers hear most weeks is whether starting the injection means giving up eating normally. The honest answer is that most people eat less because they want to, not because the medicine forces them to. If you are weighing up your options, our page on the daily weight loss injection explains how a different dosing schedule compares for those who prefer not to inject weekly. Protein, hydration and regular movement remain important alongside the treatment, and your prescribing team will talk you through the lifestyle side at every review.

Step 2: the starting dose and the titration schedule

Mounjaro comes in six UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Every course begins at 2.5 mg. The first pen's job is adjustment (settling your digestive system before the dose climbs) and most people notice that any nausea they experience is milder at this stage than it would be if treatment started higher.

After four weeks, the prescriber typically moves the dose to 5 mg, then upward in four-week steps as tolerance and response are assessed. Nobody moves up automatically; each increase is a clinical decision. If you are researching what the full range of weight loss injections involves, this titration approach is standard across GLP-1 and dual-agonist treatments.

The pen itself is a pre-filled KwikPen delivering four weekly doses. Each injection goes into the fatty tissue just under the skin, the abdomen, thigh or upper arm are all suitable sites. Rotating the exact spot within each area each week helps avoid any localised irritation. The Mounjaro patient information leaflet, available on the medicines.org.uk eMC, contains the precise injection and storage guidance that supplements what your prescriber explains.

Step 3: side effects and when to seek help

The most common side effects are gastrointestinal: nausea, loose stools, constipation, burping, indigestion and occasional vomiting. These tend to be most noticeable in the first few days after a new or higher dose and often settle within one to two weeks. Fatigue and mild headaches are reported by some people, particularly early in treatment.

A smaller number of people experience more significant effects. Severe stomach pain (especially pain that moves toward the back and does not ease) should be assessed by a doctor promptly. The MHRA issued a specific Drug Safety Update in January 2026 highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the Yellow Card scheme exists for patients to report suspected side effects directly to the regulator. If you develop symptoms of a serious allergic reaction, stop the injection and get medical help immediately.

Some people ask about storage: the pen is kept refrigerated between 2°C and 8°C. Refer to the patient leaflet for the exact window during which it can be kept at room temperature, since travelling with the medication or being away from a fridge is a practical concern the leaflet addresses precisely. A sharps container is the correct way to dispose of used needles safely.

Who the monjaro weight loss injections are licensed for

The licensed UK criteria cover adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition, for example, high blood pressure, high cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone does not determine suitability; a prescriber reviews medical history, current medicines and individual circumstances before approving treatment.

Mounjaro is not licensed for people under 18, and it is not recommended during pregnancy, while breastfeeding, or for anyone actively trying to conceive. Women taking oral contraceptive pills should discuss contraceptive cover with their prescriber at the start of treatment, as absorption of the pill may be temporarily reduced in the early weeks. Our page on manjaro weight loss injections goes into further detail on eligibility considerations that come up frequently at the consultation stage.

For context on how to access weight loss injections through a regulated UK pharmacy, including what a clinical consultation involves, that page covers the process in detail. NICE appraised tirzepatide in December 2024 (TA1026) and recommended it within specific NHS criteria; private prescribing operates under the same licensed eligibility but without the NHS waiting-list requirement. People who have come across tirzepatide under a different brand name can find a full explanation on our page about the manjaros weight loss injection, and those who have seen it referred to by yet another name may find our page on the mon weight loss injection useful for clearing up any confusion. Information on the broader range of weight loss treatments we offer, and how to start a free consultation, is on our treatments page.

If anything on this page has raised questions about your own situation, the right next step is a clinical conversation rather than another search. Our clinical team reviews every consultation personally. You can also browse our weight loss overview or check our frequently asked questions for more background before you decide.